购物车
- 全部删除
您的购物车当前为空
Anti-ERK2 Antibody (4F551)
还可以产品编号 TMAY-00113
别名 Prkm1, p42-MAPK, Mitogen-activated protein kinase 1, Mapk1, MAPK 2, MAPK 1, Mapk, MAP kinase 2, MAP kinase 1, ERT1, ERK-2, Erk2
Anti-ERK2 Antibody (4F551) 是一种 Rabbit 抗体，靶向 ERK2。Anti-ERK2 Antibody (4F551) 可用于 ELISA,FCM。
Anti-ERK2 Antibody (4F551)
Anti-ERK2 Antibody (4F551)
还可以产品编号 TMAY-00113 别名 Prkm1, p42-MAPK, Mitogen-activated protein kinase 1, Mapk1, MAPK 2, MAPK 1, Mapk, MAP kinase 2, MAP kinase 1, ERT1, ERK-2, Erk2
Anti-ERK2 Antibody (4F551) 是一种 Rabbit 抗体，靶向 ERK2。Anti-ERK2 Antibody (4F551) 可用于 ELISA,FCM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 100 μL | ¥ 2,294 | 5日内发货 |
大包装 & 定制
加入购物车
TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。
联系我们获取更多批次信息
资源下载
产品介绍
生物活性
偶联与修饰
抗原信息
| 产品描述 | Anti-ERK2 Antibody (4F551) is a Rabbit antibody targeting ERK2. Anti-ERK2 Antibody (4F551) can be used in ELISA,FCM. |
| 别名 | Prkm1, p42-MAPK, Mitogen-activated protein kinase 1, Mapk1, MAPK 2, MAPK 1, Mapk, MAP kinase 2, MAP kinase 1, ERT1, ERK-2, Erk2 |
| Ig Type | Monoclonal Rabbit IgG |
| 克隆号 | 4F551 |
| 交叉反应 | Human |
| 验证活性 | Flow cytometric analysis of Human ERK2 expression on HeLa cells. The cells were treated according to manufacturer’s manual (BD Pharmingen™ Cat. No. 554714), stained with purified anti-Human ERK2, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
| 应用 | ELISA,FCM |
| 推荐剂量 | ELISA: 1:5000-1:10000; FCM: 1:25-1:100 |
| 抗体种类 | Monoclonal |
| 宿主来源 | Rabbit |
| 构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Human ERK2 / MAPK1 / MAPK2 (rh ERK2 / MAPK1 / MAPK2; TMPY-04539; NP_002736.3; Met1-Ser360). |
| 纯化方式 | Protein A |
| 性状 | Liquid |
| 缓冲液 | 0.2 μm filtered solution in PBS |
| 研究背景 | MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation, and development. ERK is a versatile protein kinase that regulates many cellular functions. Growing evidence suggests that extracellular signal-regulated protein kinase 1/2 (ERK1/2) plays a crucial role in promoting cell death in a variety of neuronal systems, including neurodegenerative diseases. It is believed that the magnitude and the duration of ERK1/2 activity determine its cellular function. Activation of ERK1/2 is implicated in the pathophysiology of spinal cord injury (SCI). ERK2 signaling is a novel target associated with the deleterious consequences of spinal injury. ERK-2, also known as mitogen-activated protein kinase 1 (MAPK1), is a member of the protein kinase superfamily and MAP kinase subfamily. MKP-3 is a dual-specificity phosphatase exclusively specific to MAPK1 for its substrate recognition and dephosphorylating activity. The activation of MAPK1 requires its phosphorylation by upstream kinases. Upon activation, MAPK1 translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. MAPK1 is involved in both the initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating some transcription factors such as ELK1. MAPK1 acts as a transcriptional repressor that represses the expression of interferon gamma-induced genes. Transcriptional activity is independent of kinase activity. The nuclear-cytoplasmic distribution of ERK2 is regulated in response to various stimuli and changes in a cell context. Furthermore, the nuclear flux of ERK2 occurs by several energy- and carrier-dependent and -independent mechanisms. ERK2 has been shown to translocate into and out of the nucleus by facilitated diffusion through the nuclear pore, interacting directly with proteins within the nuclear pore complex, as well as by karyopherin-mediated transport. ERK2 interacts with the PDE4 catalytic unit by binding to a KIM (kinase interaction motif) docking site located on an exposed beta-hairpin loop and an FQF (Phe-Gln-Phe) specificity site located on an exposed alpha-helix. These flank a site that allows phosphorylation by ERK, the functional outcome of which is orchestrated by the N-terminal UCR1/2 (upstream conserved region 1 and 2) modules.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| 偶联 | Unconjugated |
| 免疫原 | Recombinant Human ERK2 / MAPK1 / MAPK2 Protein (TMPY-04539) |
| 抗原种属 | Human |
| 研究领域 | Cancer Drug Targets |
存储&运输
| 储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| 运输方式 | Shipping with blue ice. |
SCI 文献
计算器
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
评论列表
预览
Related Tags: buy Anti-ERK2 Antibody (4F551) | purchase Anti-ERK2 Antibody (4F551) | Anti-ERK2 Antibody (4F551) cost | order Anti-ERK2 Antibody (4F551)
嗨！有任何问题？点我咨询
评论内容